Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global LVAD Market by Type (BTT Therapy, BTD Therapy, Destination Therapy, BTR Therapy), By Application (Hospitals, Ambulatory Surgical Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global LVAD Market by Type (BTT Therapy, BTD Therapy, Destination Therapy, BTR Therapy), By Application (Hospitals, Ambulatory Surgical Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 296417 4200 Medical Devices & Consumables 377 206 Pages 4.7 (39)
                                          

Market Overview:


The global LVAD market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of heart failure, technological advancements in LVAD devices, and rising number of approvals for LVAD devices by regulatory authorities. The global LVAD market is segmented on the basis of type into BTT therapy, BTD therapy, destination therapy, and BTR therapy. The BTT therapy segment is expected to account for the largest share of the global LVAD market in 2018 owing to its growing popularity among patients with heart failure. By application, hospitals are expected to account for the largest share of the global LVAD market in 2018 followed by ambulatory surgical centers (ASCs).


Global LVAD Industry Outlook


Product Definition:


LVAD is an abbreviation for left ventricular assist device. It is a medical device that helps pump blood from the left ventricle of the heart to the rest of the body. LVADs are often used as a bridge to transplant, meaning they help keep someone alive until they can receive a new heart.


BTT Therapy:


BTT therapy, also known as blood transfusion therapy is used to treat patients with low blood volume and/or low blood pressure. It involves the infusion of a patient’s or donors’ own blood into the circulatory system of a patient who has suffered from severe bleeding. BTT is most commonly used in cases where there are no suitable alternatives such as coagulation factor concentrates or fresh frozen plasma.


BTD Therapy:


BTD therapy is a combination of two drugs, Baycol (dextromethorphan/quinidine) and Nuedexta (dextromethorphan/quinidine). It has been used in the treatment of heart failure with reduced ejection fraction. BTD reduces the symptoms and signs of congestive heart failure by improving cardiac function.


Application Insights:


Based on application, the global LVAD market is segmented into hospitals and ambulatory surgical centers. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of cardiovascular diseases that require long-term care and a large number of heart transplant surgeries every year. In addition, an increasing number of patients suffering from end-stage heart failure are undergoing dialysis or having kidney transplants, which further drives demand for long-term cardiac care and supportive therapy which includes LVADs.


The ambulatory surgical center (ASC) segment is expected to grow at the fastest rate during the forecast period due to rising awareness about ASCs among patients with nonurgent medical conditions such as diabetes mellitus type 2 or chronic renal failure requiring a longer stay in hospital than anticipated. Furthermore, growing initiatives by private healthcare providers for setting up permanent facilities at convenient locations near patient homes will boost growth further over the forecast period.


Regional Analysis:


North America dominated the global LVAD market in 2017. This can be attributed to the presence of a large number of patients suffering from heart failure, increasing healthcare expenditure and technological advancements in cardiac care. Moreover, growing awareness about advanced technologies for treating heart failure is also expected to drive growth during the forecast period.


Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness about emerging therapies for treating heart failure. Furthermore, an increase in government initiatives aimed at improving treatment options for patients suffering from cardiac disorders is further anticipated to boost demand during the projected time frame. For instance, The Government of India has launched “Swachhata Hi Seva” (Cleanliness drives) scheme with an aim towards creating healthy environments free from filth that would ultimately lead towards improved health outcomes among people affected with cardiovascular diseases such as stroke or coronary artery disease (CAD).


Growth Factors:


  • Increasing prevalence of heart failure: The global prevalence of heart failure is expected to increase from 26 million in 2010 to over 40 million by 2030. This will create a large pool of patients who could potentially benefit from LVAD therapy.
  • Advances in technology and device design: LVAD technology is constantly evolving, with new devices becoming smaller, more efficient and easier to implant. This will help make LVAD therapy more accessible to a wider range of patients.
  • Growing awareness and acceptance of LVAD therapy: There is growing awareness and acceptance of LVAD therapy among both physicians and patients alike. This is helping to drive adoption rates for the treatment modality worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

LVAD Market Research Report

By Type

BTT Therapy, BTD Therapy, Destination Therapy, BTR Therapy

By Application

Hospitals, Ambulatory Surgical Centers

By Companies

Abiomed, Berlin Heart, HeartWare International, Jarvik Heart, Abbott, Cardiac Assist, Evaheart, ReliantHeart, Sun Medical Technology Research, Sunshine Heart, Abiomed

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

206

Number of Tables & Figures

145

Customization Available

Yes, the report can be customized as per your need.


Global LVAD Market Report Segments:

The global LVAD market is segmented on the basis of:

Types

BTT Therapy, BTD Therapy, Destination Therapy, BTR Therapy

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Ambulatory Surgical Centers

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abiomed
  2. Berlin Heart
  3. HeartWare International
  4. Jarvik Heart
  5. Abbott
  6. Cardiac Assist
  7. Evaheart
  8. ReliantHeart
  9. Sun Medical Technology Research
  10. Sunshine Heart
  11. Abiomed

Global LVAD Market Overview


Highlights of The LVAD Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. BTT Therapy
    2. BTD Therapy
    3. Destination Therapy
    4. BTR Therapy
  1. By Application:

    1. Hospitals
    2. Ambulatory Surgical Centers
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the LVAD Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global LVAD Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


LVAD stands for left ventricular assist device. It is a mechanical device that helps the heart pump blood. LVADs are used in people who have heart failure and cannot get enough oxygen to their cells because of a problem with their lungs or heart.

Some of the major players in the lvad market are Abiomed, Berlin Heart, HeartWare International, Jarvik Heart, Abbott, Cardiac Assist, Evaheart, ReliantHeart, Sun Medical Technology Research, Sunshine Heart, Abiomed.

The lvad market is expected to grow at a compound annual growth rate of 10.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 LVAD Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 LVAD Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 LVAD Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the LVAD Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global LVAD Market Size & Forecast, 2018-2028       4.5.1 LVAD Market Size and Y-o-Y Growth       4.5.2 LVAD Market Absolute $ Opportunity

Chapter 5 Global LVAD Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 LVAD Market Size Forecast by Type
      5.2.1 BTT Therapy
      5.2.2 BTD Therapy
      5.2.3 Destination Therapy
      5.2.4 BTR Therapy
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global LVAD Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 LVAD Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Ambulatory Surgical Centers
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global LVAD Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 LVAD Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America LVAD Analysis and Forecast
   9.1 Introduction
   9.2 North America LVAD Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America LVAD Market Size Forecast by Type
      9.6.1 BTT Therapy
      9.6.2 BTD Therapy
      9.6.3 Destination Therapy
      9.6.4 BTR Therapy
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America LVAD Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Ambulatory Surgical Centers
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe LVAD Analysis and Forecast
   10.1 Introduction
   10.2 Europe LVAD Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe LVAD Market Size Forecast by Type
      10.6.1 BTT Therapy
      10.6.2 BTD Therapy
      10.6.3 Destination Therapy
      10.6.4 BTR Therapy
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe LVAD Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Ambulatory Surgical Centers
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific LVAD Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific LVAD Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific LVAD Market Size Forecast by Type
      11.6.1 BTT Therapy
      11.6.2 BTD Therapy
      11.6.3 Destination Therapy
      11.6.4 BTR Therapy
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific LVAD Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Ambulatory Surgical Centers
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America LVAD Analysis and Forecast
   12.1 Introduction
   12.2 Latin America LVAD Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America LVAD Market Size Forecast by Type
      12.6.1 BTT Therapy
      12.6.2 BTD Therapy
      12.6.3 Destination Therapy
      12.6.4 BTR Therapy
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America LVAD Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Ambulatory Surgical Centers
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) LVAD Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) LVAD Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) LVAD Market Size Forecast by Type
      13.6.1 BTT Therapy
      13.6.2 BTD Therapy
      13.6.3 Destination Therapy
      13.6.4 BTR Therapy
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) LVAD Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Ambulatory Surgical Centers
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 LVAD Market: Competitive Dashboard
   14.2 Global LVAD Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 Abiomed
      14.3.2 Berlin Heart
      14.3.3 HeartWare International
      14.3.4 Jarvik Heart
      14.3.5 Abbott
      14.3.6 Cardiac Assist
      14.3.7 Evaheart
      14.3.8 ReliantHeart
      14.3.9 Sun Medical Technology Research
      14.3.10 Sunshine Heart
      14.3.11 Abiomed

Our Trusted Clients

Contact Us